Zobrazeno 1 - 10
of 85
pro vyhledávání: '"H Brailly"'
Autor:
Hervé Brailly, Eric Postaire, Pierrette Zorzi, L. Becquemont, F. Bassompierre, B. Dreno, S. Lucas-Samuel, M. Pallardy, S. Scholl, M. Bonneville, P. Zorzi, E. Postaire, P.-Y. Arnoux, I. Barilero, E. Caugant, D. Debiais, M. Gersberg, J. Tiollier, H. Brailly, Y. Kabrane, J.-L. Romet-Lemonne, P. Squiban, S. Solbès Latourette
Publikováno v:
Therapies. 59:305-310
Resume Le sujet de la table ronde etant initialement tres vaste, il avait ete convenu avec les participants de le recentrer sur les therapies cellulaires (TC) impliquant des cellules autologues utilisees dans des situations de reconstruction tissulai
Autor:
Hervé Brailly, Eric Postaire, Pierrette Zorzi, L. Becquemont, F. Bassompierre, B. Dreno, S. Lucas-Samuel, M. Pallardy, S. Scholl, M. Bonneville, P. Zorzi, E. Postaire, P.-Y. Arnoux, I. Barilero, E. Caugant, D. Debiais, M. Gersberg, J. Tiollier, H. Brailly, H. Kabrane, J.-L. Romet-Lemonne, P. Squiban, S. Solbès Latourette
Publikováno v:
Therapies. 59:311-316
The topic of the round table being very broad, it was agreed with the participants that the discussion should be focused on autologous cell therapy (CT) used in tissue repair, immunomodulation or gene transduction. Autologous CT is actually comprised
Publikováno v:
Clinical Chemistry. 40:116-123
Determinations of total cytokine concentration in biological fluids by immunoassays face two major problems: the biochemical heterogeneity of the analyte and the interference of cytokine-binding proteins. We developed an ultrasensitive enzyme immunoa
Publikováno v:
The Journal of Immunology. 149:2255-2261
The T cell adhesion molecule CD28 provides a costimulatory signal in combination with CD2 and CD3 mAb. CD28 regulates the expression of cytokines by T cells, not only IL-2, but also IL-1 alpha and CSF-1, usually synthesized by accessory cells. We hav
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 5:15-20
Summary The antigen-antibody reactions occurring at interfaces present several differences for homologous reactions in solution. Firstly, we observed an affinity enhancement due to the formation of ring structures on the interface; the other effects
Autor:
F, Sayani, F A, Montero-Julian, V, Ranchin, J M, Prevost, S, Flavetta, W, Zhu, R C, Woodman, H, Brailly, C B, Brown
Publikováno v:
Blood. 95(2)
On the basis of the finding of alternatively spliced mRNAs, the alpha-subunit of the receptor for GM-CSF is thought to exist in both a membrane spanning (tmGMRalpha) and a soluble form (solGMRalpha). However, only limited data has been available to s
Autor:
S. Flavetta, H. Brailly, C. Ronsin, R. Breathnach, L. Xerri, I. Dauny, F.A. Montero-Julian, F. André, J. Marvaldi, M.H. Wang
Publikováno v:
Hybridoma. 17(6)
RON is a receptor protein tyrosine kinase belonging to the hepatocyte growth factor (HGF) receptor family. Using Recepteur d'Origine Nantais (RON) transfected cell lines, Macrophage Stimulating Protein (MSP) was identified as the ligand of RON. RON i
Autor:
Y. Jacques, S. Minvielle, G. Müller-Newen, P.C. Heinrich, J. Grötzinger, F. Montero-Julian, H. Brailly, J.M. Wilkin, J. Content
Publikováno v:
Research in immunology. 149(7-8)
Autor:
F A, Montero-Julian, H, Brailly, C, Sautès, I, Joyeux, T, Dorval, V, Mosseri, K, Yasukawa, J, Wijdenes, A, Adler, I, Gorin, W H, Fridman, E, Tartour
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(8)
gp130 acts as a common transducing signal chain for all receptors belonging to the interleukin (IL)-6 receptor family. The IL-6-related cytokines [IL-6, IL-11, oncostatin M (OSM), leukemia inhibitory factor, ciliary neurotrophic factor, and cardiotro
Autor:
D, Han, C, Pottin-Clemenceau, M A, Imro, M, Scudeletti, C, Doucet, F, Puppo, D, Brouty-Boye, J, Vedrenne, Y, Sahraoui, H, Brailly, A, Poggi, C, Jasmin, B, Azzarone, F, Indiveri
Publikováno v:
Oncogene. 12(5)
Human melanomas may express both in vivo and in vitro functional IL-Rs and may be expected to directly respond to injected IL2. This may generate biological situations which may be favourable for the patient, but also for tumor progression. Here, we